Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Alvogen
FDA Approves HYDROCODONE BITARTRATE — Alvogen Inc.

Alvogen Inc. filed a new generic application (ANDA206986) for oral hydrocodone bitartrate on January 21, 2020. This approval is expected to intensify ...

Granules
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Granules Pharmaceuticals Inc.

Granules Pharmaceuticals Inc. announced the FDA approval of its ANDA for Hydrocodone Bitartrate and Acetaminophen, granting the company a strategic en...

Daiichi
FDA Approves ENHERTU — Daiichi Sankyo Inc.

# FDA Approves Daiichi Sankyo's ENHERTU for HER2-Positive Cancers The FDA has approved Daiichi Sankyo Inc.'s ENHERTU (fam-trastuzumab deruxtecan-nxki...

SEAGEN
FDA Approves PADCEV EJFV — SEAGEN INC.

The U.S. FDA has approved the INDICATION for Enfortumab Vedotin (Padcev EJFV) for INITIATED TREATMENT of LOCALIZED MUSCOSAL SQUAMOUS CELL CARCINOMA (U...

CONCORD
FDA Approves MYCOPHENOLIC ACID — CONCORD BIOTECH LIMITED

Concord Biotech Limited announced the FDA approval of its ANDA for Mycophenolate Sodium Oral Suspension, providing a crucial oral bioequivalent to Myc...

Cipla
FDA Approves VIGABATRIN — Cipla USA, Inc.

# FDA Approves Vigabatrin Generic from Cipla USA Cipla USA, Inc. received FDA approval for its generic vigabatrin oral formulation, expanding the com...

Shionogi
FDA Approves FETROJA — Shionogi Inc.

Shionogi Inc. announced the FDA approval of FETROJA (cefiderocol sulfate tosylate) Intravenous injection for the treatment of certain hospital-acquire...

Sun
FDA Approves ABSORICA LD — Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries, Inc. secured FDA approval for oral isotretinoin brand Absorica LD, positioning the Indian pharma giant to capture signi...

Sandoz
FDA Approves ZIEXTENZO — Sandoz Inc

Sandoz Inc. has secured FDA approval for the biosimilar PEGFILGRASTIM-BMEZ (ZIEXTENZO), filling a major void in the market for a subcutaneous granuloc...

U.S.
FDA Approves IBRANCE — U.S. Pharmaceuticals

The U.S. FDA has approved oral palbociclib (IBRANCE, NDA212436) manufactured by U.S. Pharmaceuticals, a move that broadens the accessibility of this w...

ScieGen
FDA Approves NAPROXEN SODIUM — ScieGen Pharmaceuticals, Inc.

ScieGen Pharmaceuticals, Inc. has received FDA approval for its Abbreviated New Drug Application for Naproxen Sodium, launching an additional generic ...

Vertex
FDA Approves TRIKAFTA — Vertex Pharmaceuticals Incorporated

# FDA Approves Vertex Pharmaceuticals' TRIKAFTA for Cystic Fibrosis Vertex Pharmaceuticals Incorporated announced FDA approval of TRIKAFTA (elexacaft...

ANI
FDA Approves ACETAZOLAMIDE — ANI Pharmaceuticals, Inc.

# FDA Approves ANI Pharmaceuticals' Generic Acetazolamide ANI Pharmaceuticals, Inc. received FDA approval for its generic acetazolamide oral formulat...

Gland
FDA Approves NEOSTIGMINE METHYLSULFATE — Gland Pharma Limited

Gland Pharma Limited announced that the FDA has approved the ANDA for Neostigmine Methylsulfate, a cholinesterase inhibitor indicated for the reversal...

Cranbury
FDA Approves DOXYCYCLINE — Cranbury Pharmaceuticals, LLC

Cranbury Pharmaceuticals, LLC received FDA approval on October 7, 2019, for Doxycycline Hyclate oral tablets, expected to increase generic supply and ...

Upsher-Smith
FDA Approves TESTOSTERONE — Upsher-Smith Laboratories, LLC

Upsher-Smith Laboratories announced on September 23, 2019, that the Food and Drug Administration had approved its generic testosterone formulation for...

Ajanta
FDA Approves DOXEPIN HYDROCHLORIDE — Ajanta Pharma USA Inc.

Ajanta Pharma USA Inc. received FDA approval on September 13, 2019, for the oral generic of doxepin hydrochloride. The approval is expected to impact ...

Elite
FDA Approves ACETAMINOPHEN AND CODEINE PHOSPHATE — Elite Laboratories, Inc.

Elite Laboratories, Inc. secured FDA approval for its generic Acetaminophen and Codeine Phosphate tablets (ANDA 212418), opening a pathway to capture ...

Novadoz
FDA Approves FOSAPREPITANT — Novadoz Pharmaceuticals LLC

Novadoz Pharmaceuticals received FDA approval on Friday for the generic version of the antiemetic Fosaprepitant dimeglumine (ANDA209965), signaling fu...

BE
FDA Approves FOSAPREPITANT — BE Pharmaceuticals Inc.

BE Pharmaceuticals Inc. received U.S. approval for the intravenous formulation of fosaprepitant dimeglumine, positioning the company to compete in the...